Tag: Pharmaceuticals
New Jersey District Court Limits Actavis To Cash Payments
This article is part of a Chronicle. See more from this Chronicle
Donald Falk, Christopher Kelly, Apr 29, 2014
As with patent infringement litigation in many...
Canada Considers Hopping on Board with a Product-Hopping Case
This article is part of a Chronicle. See more from this Chronicle
George Addy, Erika Douglas, Mar 26, 2014
The Canadian Competition Bureau has been signaling...
Pay-for-Delay
Fiona Scott Morton, Dec 20, 2013
This article lays out the economics of competition between branded and generic pharmaceuticals and its welfare consequences. I explain...
“Pay-for-Delay”: What Do We Disagree On?
Pierre Regibeau, Dec 20, 2013
Antitrust concerns about “pay-for-delay” patent settlements are based on two theories of harms, one that stresses the need for courts...
Competition Authorities Support Grasshoppers: Competition Law as a Threat to Innovation
Sir Robin Jacob, Dec 20, 2013
Aesop’s fable is of the ant and the grasshopper. In summer the ant works, gathering and storing food against...
Evaluating the Size of Reverse Payments In Light of the Supreme...
James Langenfeld, Dec 30, 2013
Patent settlement agreements that involve payments from brand-name drug manufacturers to generic drug manufacturers (so called "reverse payments" or "pay...
Reverse Payment Settlement Cases: Under the Rule of Reason By Object?...
Marleen Van Kerckhove, Sep 30, 2013
The EC's 2009 Sector Inquiry Report on certain practices in the European pharmaceutical sector described in considerable detail the practice...
Canadian Perspectives on Competition Law and Reverse Payments Following FTC v....
David Rosner, Navin Joneja, Joshua Krane, Sep 30, 2013
The Canadian Competition Bureau, pharmaceutical companies operating in Canada, and Canadian lawyers have been following the...
Reverse Payment Settlements in the United States and Europe: Moving Toward...
David Tayar, William Rooney, Agathe Richard, Sep 30, 2013
After more than a decade of debate and complex litigation on "reverse payment" settlements, the Supreme...
FTC v. Actavis: Has the Dust Really Settled?
Kyle Musgrove, Richard Ripley, Sep 30, 2013
Three months now have passed following the Supreme Court's decision inFTC v. Actavis, 133 S. Ct. 2223 (2013),...
